Development of a Model Based on Physical Mechanisms for the Explanation of Drug Release: Application to Diclofenac Release from Polyurethane Films by ABBASNEZHAD, Navideh et al.
Science Arts & Métiers (SAM)
is an open access repository that collects the work of Arts et Métiers Institute of
Technology researchers and makes it freely available over the web where possible.
This is an author-deposited version published in: https://sam.ensam.eu
Handle ID: .http://hdl.handle.net/10985/20316
This document is available under CC BY license
To cite this version :
Navideh ABBASNEZHAD, Mohamed KEBDANI, Mohammadali SHIRINBAYAN, Stéphane
CHAMPMARTIN, Abbas TCHARKHTCHI, Smaine KOUIDRI, Farid BAKIR - Development of a
Model Based on Physical Mechanisms for the Explanation of Drug Release: Application to
Diclofenac Release from Polyurethane Films - Polymers - Vol. 13, n°8, p.1230 - 2021




Development of a Model Based on Physical Mechanisms for the
Explanation of Drug Release: Application to Diclofenac Release
from Polyurethane Films
Navideh Abbasnezhad 1,2,* , Mohamed Kebdani 1, Mohammadali Shirinbayan 1,2 , Stéphane Champmartin 1 ,
Abbas Tcharkhtchi 2, Smaine Kouidri 1 and Farid Bakir 1


Citation: Abbasnezhad, N.; Kebdani,
M.; Shirinbayan, M.; Champmartin,
S.; Tcharkhtchi, A.; Kouidri, S.; Bakir,
F. Development of a Model Based on
Physical Mechanisms for the
Explanation of Drug Release:
Application to Diclofenac Release
from Polyurethane Films. Polymers
2021, 13, 1230. https://doi.org/
10.3390/polym13081230
Academic Editor: Ki Hyun Bae
Received: 24 March 2021
Accepted: 7 April 2021
Published: 10 April 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Arts et Metiers Institute of Technology, CNAM, LIFSE, HESAM University, F-75013 Paris, France;
mohamed.kebdani@ensam.eu (M.K.); mohammadali.shirinbayan@ensam.eu (M.S.);
stephane.champmartin@ensam.eu (S.C.); smaine.kouidri@ensam.eu (S.K.); farid.bakir@ensam.eu (F.B.)
2 Arts et Metiers Institute of Technology, CNAM, PIMM, HESAM University, F-75013 Paris, France;
abbas.tcharkhtchi@ensam.eu
* Correspondence: navideh.abbasnezhad@ensam.eu
Abstract: In this study, we present a method for prediction of the drug-release profile based on
the physical mechanisms that can intervene in drug release from a drug-carrier. The application
presented here incorporates the effects of drug concentration and Reynolds number defining the
circulating flow in the testing vein. The experimental data used relate to the release of diclofenac
from samples of non-degradable polyurethane subjected to static and continuous flow. This case
includes simultaneously three mechanisms: burst-release, diffusion and osmotic pressure, identified
beforehand here as being able to contribute to the drug liberation. For this purpose, authors coded the
Sequential Quadratic Programming Algorithm to solve the problem of non-linear optimization. The
experimental data used to develop the mathematical model obtained from release studies carried out
in water solution at 37 ◦C, for three concentrations of diclofenac and two water flow rates. We discuss
the contribution of mechanisms and kinetics by considering two aforementioned parameters and,
following that, we obtain the specific-model and compare the calculated results with the experimental
results for the reserved cases. The results showed that drug percentage mostly affect the burst release,
however flow rate has affected the osmotic release. In addition, release kinetics of all the mechanisms
have increased by increasing the values of two considered parameters.
Keywords: physical mechanism; modeling; kinetic; drug release
1. Introduction
The drug-release profile of drug-delivery systems gives them their efficacy [1]. In-
deed, achieving an amount of drug released within a range of the chosen therapeutic
window is, for example, an important characteristic sought by researchers [2]. Studies
have always tried to design a system with controlled drug release to obtain a desirable
release profile [3].
In order to improve the design and achieve the desired release profile from the carriers,
it is important to identify the mechanisms interacting in the release system [4,5]. Indeed,
to minimize the entropy level of the delivery systems, physical mechanisms occur, which
thus leads to the drug-release process [6]. Therefore, physical and chemical mechanisms
occurring during the release characterize the release profile.
Usually, drug-release mechanisms from the polymer carriers include diffusion, degra-
dation, swelling, osmosis, etc. Each of these phenomena can lead to a specific release of the
drug from the carrier [7,8].
For each mechanism, diverse factors affect the release kinetics [9–11]. Among these
factors, temperature [12], initial drug load [13], circulating flow [14] pH [15,16], ionic
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strength, redox and enzymes are, for example, elements whose influence deserves to be
studied. In addition, many studies have been conducted to explore the possibilities offered
by polymeric biomaterials in regulating drug liberation from stimuli-responsive drug
delivery systems. Indeed, drug release could be regulated in response to both human body
stimuli [17] and external signals [18]. It is worth mentioning drug release from carriers
occurs by one or over one mechanism happening simultaneously or successively. These
mechanisms contribute to a part of the global quantity liberated, and each can be affected
by the variation of certain factors. Amounts of the drug liberated are limited between 0%
and 100% of the global released quantity [19,20]. Therefore, various mechanisms governing
drug release need to be adequately investigated. The associated mechanisms are related to
the polymer and the drug [21,22]. For many polymers and drugs, the factors influencing
the release can vary [23,24]. It is essential to notice the physicochemical properties of the
drug, and the matrix can influence the mechanisms. For example, the solubility of particles,
permeability and the size of matrix pores. Because of the desirable physical-mechanical
properties and biocompatibility [25,26], polyurethanes (PUs) are commonly used in surgical
implants and other in vivo products [27]. Based on the physicochemical properties of these
carriers, the following mechanisms were identified: Non-trapped drugs in the pores stored
on the carrier-surface especially for the hydrophilic drugs induce the burst release [28,29].
However, the trapped drug particles are liberated by other mechanisms like the diffusion,
degradation and osmosis [30,31]. The osmosis mechanism is detected by the rapid water
absorption or swelling of the non-degradable hydrophilic polymer. Its magnitude is
enhanced when the hydrophilic solute is incorporated in the matrix [32,33]. This system is
based on osmotic pressure, pushing the solvent through the semi-permeable membrane
until there is a balance between the inside and the outside. It is notable that in this case the
degradability of the system should be negligible [34].
Mathematical modeling is essential in predicting the liberation and kinetic profile
by considering the controlling drug release mechanisms. In particular, to facilitate the
development of the drug carriers and economizing the time and cost by decreasing the
number of experiments in the trial error method.
Mathematical models for the evaluation of drug-release profiles proceed by solving
the equations of the involved physical mechanisms [14,16]; and considering the evolution
of kinetics [35,36].
The method used in this study is the sequential quadratic programming algorithm [37],
which represents a method that addresses a nonlinear optimization problem. Such an
approach is to determine the factors, which reduce a function while maintaining equality
and/or inequality conditions on certain other factors. It is a Newtonian algorithm extended
to first order optimality conditions.
The method selected is employed to applications of a non-degradable polyurethane
matrix loaded with specific doses of the anti-inflammatory hydrophilic drug (diclofenac
epolamine). Experimental data used consider several flow rates of the fluid circulating in a
bio-reactor simulating in vitro blood-flow in stented arteries [14]. Identified mechanisms
for these polymeric carriers are burst-release, diffusion and osmosis. This article discusses
the mechanisms contributing to drug release and the material and environmental factors of
in vitro assays influencing the kinetic profile. Finally, the dependence of the initial drug
concentration and the flow rate on the liberation factors; the burst-release constant kb,
effective diffusion coefficient De, and osmotic gradient ∆π were obtained and used for
modeling and comparing cases reserved for the verification.
2. Materials and Methods
2.1. Proposed Method
The method developed in this work is illustrated on the flowchart given in Figure 1.
It involves: (i) determining, from a database of well-documented trials, the ratios cor-
responding to the release mechanisms identified. (ii) By solving a system of non-linear
equations, modeling the optimization problem and containing the unknowns for this
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database. (iii) Developing from these results a specific model simulating the influence of
the factors kept. (iv) To validate the model thus constructed on the part of the test-data
reserved for this action.
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Figure 1. Flo chart of the proposed ethod.
I this section, the d veloped mathematical model is presented. The proposed method
consists of solving a non-linear equations system modeling the all mechanisms identified:
burs -release, diffusion, swelling, osmotic pressure, etc. Th method op rated, known
as ne of the m st effective optimization procedures for solving n n-linear optimization
problems, is sequential adratic programming algorithm. Suc a problem consists i
calculating the factors minimizing a function and simultaneously respecting the imposed
constraints. It is a Newtonian algorithm applied to th first order optimality conditions
of the system. It finds the solution f nonlinear problems through linear approximations.
The quadratic s b-problem (QP) generated is solved following to the steps described in the
flowchart bellow (shown in Figure 2).
The function “f” is differentiable, representing the physical nonlinear model that
should adjust to the experimental results. The problem is to find the vector X composed
of the unknown parameters minimizing the function f(X). This non-linear optimization
problem is subject to the following constraints:
hi(X) = 0, i = 1, 2, 3, . . . , m (1)
gj(X) = 0, j = 1, 2, 3, . . . , n (2)
The Lagrangian function relative to the current optimization problem defined as:
L(X, λ, µ) = f(X) + λh(X)T + µg(X)T (3)
where λ and µ are multiplier vectors for equality and inequality constraints, respectively. H
in Equation (4) is a Hessian matrix of the Lagrangian function, which calculates the second
derivatives of the objective function and constraint functions, h, g. As mentioned before,
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Solving Equations (4)–(6) results in a search direction for X noted, d; calculates the 
acceptable estimates for the Karush–Kuhn–Tucker (KKT) multipliers d, λ, and μ [39,40] 
updates the matrix H. There are: 
d = X − Xk, Δλ =  λ − λ𝑘, and Δµ =  µ − µk  
where Δ symbolize the step of incrementation. H matrix is updated by the Broyden–
Fletcher–Goldfarb–Shanno method. The solution converges if the vector, d, is within an 
accepted tolerance range (δ) of 0.0001, with KKT conditions fully satisfied [39,40]. A step 
Figure 2. The iterative flowchart of the quadratic programming algorithm (SQP) method [38].
Solving Equations (4)–(6) results in a search direction for X noted, d; calculates the
acceptable estimates for the Karush–Kuhn–Tucker (KKT) multipliers d, λ, and µ [39,40]
updates the matrix H. There are:
d = X − Xk, ∆λ = λ− λk, and ∆µ = µ− µk
where ∆ symbolize the step of incrementation. H matrix is updated by the Broyden–
Fletcher–Goldfarb–Shanno method. The solution converges if the vector, d, is within an
accepted tolerance range (δ) of 0.0001, with KKT conditions fully satisfied [39,40]. A step
size α is set to ensure the decrease of the objective function [41]. The iterative solution
technique described above is repeated until the solution X is obtained. This optimization
algorithm is programmed under Matlab software.
The total release profi e is consist of different mechanisms contributed in the drug lib-
eration. Therefore, the sum of these mechanisms multiply to the percentage of participation
results in the relea e profile:







µi × Fi (7)
Examples of equations describing mechanisms are given in the case presented in the
section below.
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2.2. Case Study
In this study, we used the experimental results of diclofenac epolamine (DE) release.
DE is an anti-inflammatory and a model of the hydrophilic drug (water solubility of
5.55 mg/mL [42]), used in this regard, from the non-degradable polyurethane samples.
The samples were prepared with the synthesis of hardener consisting of isocyanate type
4,4-diphenylmethylene diisocyanate (MDI) and resin composed of polyol, dye, and catalyst.
The ultimate product consists of a mixture of the resin and the hardener in a ratio of five
to two, and certain percentage of the drug (drug mass to the total mass of sample). The
samples were cut with the dimensions of 2 × 5 × 30 mm3. As the physical stability of the
DE in the polyurethane samples were important for considering the mechanisms of release,
therefore, it was checked during the samples preparation by microscopic observations.
Diclofenac particles were stayed in their initial particle shape, solid-state, after the samples
were prepared [14]. These experiments were carried out in vitro on samples loaded by
10%, 15% (for model verification), 20% and 30%, and assessed at four different flow rates:
0, 7.5, 6.5 (for model verification), and 23.5 mL/s. These data have made it possible to
observe and differentiate the drug-liberation profiles, in the static and the presence of a
continuous flow.
Figure 3 shows the schematic of the mechanisms occurring during the release. At
first, the fluid transports the drug particles on the surface of the sample; then the water
penetrates in the sample and dissolves particles, then the dissolved drugs release by
diffusion and/or osmotic pressure.
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Figure 3. Schematic of the phenomena occurring during the release. Yellow rectangle is the polymer
matrix, white spheres are the drug particles on the surface contacting with outside, golden spheres
are drug particles inside the polymeric matrix. The arrows show the phenomena of water absorption,
burst release and mechanisms of diffusion and osmosis.
Equations employed in this case study related to the three phenomena (burst release,




= µ1 × F1 + µ2 × F2 + µ3 × F3, ∑i=Ni=1 µi = 1, and 1 ≥ µi ≥ 0 (8)
where Mt represents the quantity of drug released at time t, M∞ is the amount initially
loaded, µi the contribution of each of the N mechanisms involved and Fi the corresponding
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where the initial mass of the release at the beginning of the experiment (t = 0) is considered




= 1− exp(−kbt) (10)
where Kb represents initial burst constant and t is the time of release. Diffusion is the period
of the release, normally followed by the slow release rate, which is happening through the







where D is the drug diffusion coefficient inside the polymer matrix, c corresponds to the
concentration of the drug in the polymer network as a function of time t and position x.
The initial presumption is that at the beginning of the trial, the drug is dispersed evenly in
the film:
t = 0, c = c initial − L ≤ x ≤ +L
where c initial indicates the initial amount of drug in the sample, and L describes the film’s
half-thickness. For the resolution of the diffusion mechanism, the hypothesis considers that
the product is homogenously distributed throughout the polymeric networks. Moreover,
the film surface is very high compared to its thickness (150 mm2/2 mm). Consequently,
edge effects are insignificant, and the statistical study can be confined to one dimension.
Under these conditions, the release kinetics can be defined in a plane sheet for the samples









where π is 3.14 and h is the thickness of the matrix. In theory, this equation is valid for the
60% of the cumulative drug release. It means 0 release fraction 0.6.
It is believed that the drug concentration far from the film’s surface is constant and
equivalent to zero since the release medium is well stirred and complete sink conditions
are established throughout the experiments [44,46]. Therefore, Equation (12) is completed
















The other related phenomenon is the osmosis, Equation (8) shows the representative










where A and h are the surface area and thickness of the polymer films (by the hypothesis
that the polymeric carrier consist of the porous structure and hydrophilic drug), K′ is
the effect of mechanical permeability (Lp) and reflection coefficient (σ), ∆π represents
the osmotic gradient across the film membrane, S is the saturation solubility of the drug
in the dissolution medium. According to the thin thickness of the samples and where
the accumulation of the water in the samples are not sufficient to induce the hydrostatic
pressure and, therefore, hydrostatic pressure inside the system is minimized as expressed
by the condition ∆π >> ∆P. Another condition is considering the boundary condition where
drug released concentration at time, t = 0 and t = t is zero and Mt respectively. Moreover, at
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t = 0, MtM∞ equals to zero, therefore, constant value as a result of the integral is equal to zero.











The final equation for the release in this system follows as below:
Mt

















µ1 + µ2 + µ3 = 1, & 1 ≥ µ1&2& 3 ≥ 0
(16)
where the values of µ1, µ2 and µ3 represent successively the proportions of the con-
tribution of the phenomena of burst-release, diffusion, and osmotic pressure. The other
unknown factors are kb, De, ∆π.
The differences of the pressure for different flow rates of the flow in the porous
membrane is calculated by the Poiseuille equation adapted for the porous media, with the




δ is the thickness of the membrane (m), Jv is the volumetric flux (m3/m2·s) and η is
the fluid viscosity (Pa·s), a is the radius of the pores (m), that the fluid flows in and n is the
density of the pores in the membrane, and:
Jv = ∆P·Lp (18)












where πeff the detected osmotic pressure and iRTC is the theorical osmotic pressure that
would be noticed in the perfectly semipermeable membrane. ∅ is the ratio of the radius of
the solute particles to the pore, where it is calculated by the SEM images.
By the values obtained from the above equations, the specific model is elaborated and
compared with the results of the experiments. The two indicators, root mean squared error

















Equation (16) combining Equations (10), (13) and (15) is used for different drug dosages
and applied flow rates.
3. Results and Discussion
Figure 4 shows the comparison between the experimental and calculated results.
Table 1 gives the values related to the percentage of the contribution of the mechanisms
associated in the drug release and affecting release kinetics.
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Figure 4. Comparing the calculated values with the Equation (16) and the experimental data of
diclofenac release from the polyurethane (PU) matrix, (a) for three different drug concentrations;
10%, 20%, and 30% at the flow rate of 7.5 mL/s (b) and for the PU with 20% of drug at the flow rates
of 0, 7.5, and 23.5 mL/s.
Table 1. Values related to the percentage of the co tribution of the mech nisms associated in the
drug release and affecting release kinetic (PU-10%DE-Q7.5 mL/s: polyurethane sample with 10%










Burst (%) 23.2 31.3 36 29 31.9
Osmosis (%) 11.1 12.8 14.7 9 14.6
Diffusion (%) 65.7 55.9 49.3 62 53.5
Kb (h−1) 1.5 2.5 3.4 1.7 3.9
∆π (atm) 0.005 0.009 0.014 0.007 0.012
De (m2/h) 1.1 × 10−8 1.62 × 10−8 1.96 × 10−8 8.7 × 10−9 2.77 × 10−8
RMSE 0.02 0.02 0.03 0.02 0.02
R2 0.99 0.98 0.97 0.98 0.99
3.1. Effect of Drug Dosage
Figure 5 represents the contribution-percentage of each three mechanisms at the drug
liberation at the flow rate of 7.5 mL/s for the three selected concentrations. One can note
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that increasing the initial drug percentage results in the increasingly higher burst release.
This phenomenon could be explained by the high drug particles delivery, at the initial time
of the liberation. This is due to the higher quantity of the drug present on the surface of the
samples or in the pores connected to the surface. It is notable that by increasing the ratio of
the drug to the total mass of the sample, more drugs can stay at the surface of the sample,
especially when the drug is hydrophilic and have the potential to stay at the surface of
the samples. Moreover, the kinetics of the release at the burst release is increasing with
the drug content. This can be due to the interconnection of the pores containing the drug
particles and increasing the feasibility of the release.
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l l t less significantly, release by the osmosis mechanism is increasing with
i iti l r loa e . One can note that it is the due to the high pores created
f t s le, hich is at the origin of this phenomenon. Ind ed, because
t unt of hydrophilic drug, the permeab lity of the membrane increase.
i is in the polymeric films are created due to the high percentage
r e , increasing the higher hydrophilic drug content increase the water
ti . Therefore, it generates the osmotic pressure from the unwetted core of the
tt si e of the sa ple. In this case, it is eviden tha the osmotic pressure
i r ercentage of the drug is higher.
te t at it is ue to the greater content of the drug especially near to the
les.
fu-
sion mechanism on the total contribut on of the releas is d creased. It is evidently b cause
of the higher drug release beforehand by the two aforementioned mechanisms. However,
the kinetics of the release by this mechanism, the diffusion coefficient, is increasing by
increasing the initial drug loaded. One can note that this is due to the higher mass of
the drug remaining in higher drug loaded samples compared to the lower drug loaded
samples, even if the percentage liberated from the total percentage is high. Therefore, there
is a higher gradient of concentration between the sample and the release medium, which
increase the diffusion coefficient of the drug release drug.
In addition, however, it seems that the diffusion mechanism can be present in all
the periods of the release but essentially, it will be the controlling mechanism after the
burst and osmosis, where the whole samples become wet and the diffusion can happen
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in all directions of the sample. Figure 6 shows the variation of the kinetic of burst release,
osmotic pressure, and diffusion coefficient versus the initial drug loaded on the samples
during the release. It is notable that the kinetics of the release for all the mechanisms by
increasing the drug percentages are enhanced. However, it is more evident respectively
for the burst release, osmosis and diffusion mechanisms. On can note that generally by
increasing the drug dosage, release time is decreasing.
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3.2. Effect of Flow Rate
Figure 8 represents the percentages of the contribution of each mechanism during the
drug release from PU films with 20% of the drug at the different flow rates of 0, 7.5 and
23.5 mL/s. One can note that by increasing the flow rate the percentage of the burst release
is increased.
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This increase is less for the two cases of continuous flow rate, but is ore visible
comparing the results of static and continuous flow. This can be due to the force of the fluid
in the continuous state to pluck out the drug particles, but in the static state the dissolution
of the drug is needed prior to release. Therefore, it is worth noting that the flow rate mostly
influence the kinetics of the burst over influencing the percentage of burst release. It is
notable that the effect of the flow rate on the burst release is less notable than the effect of
the initial drug loaded.
Increasing the flow rate also increases the osmotic pressure and more drug is released
by this mechanism. Therefore due to the high pressure of the flow for the higher flow rate,
high water is absorbed by the polymer and an elevated osmotic pressure is induced in the
polymers which results in the drug release. As the polymer and the drug used in this study
are hydrophilic, therefore, the amount of the water absorbed is high and lets the solute
dissolve in the solvent. In order to counteract the stress caused by the osmotic pressure
inside the carrier. The support reduces stress by desorption of the amount of water which
can be accompanied with the drug.
The effect of the flow rate on the osmotic pressure seems to be the force or pressure
applied to the liquid to go through the semipermeable membrane. Therefore, the values
related to osmotic pressure seem to increase by increasing the flow rate (shown in Figure 9).
In this aim, the permeability of the membrane also remains another determinant parameter
in the drug release. Figure 10 shows that the effect of the flow rate is significant on the
hydraulic permeability where it is a parameter increasing the percentage of the release by
osmotic pressure, and this relation varies linearly.
Another important mechanism which consist a large percentage of the release is
diffusion. The lower percentage of the drug released with increasing the flow rate is related
to the high amount of drug released beforehand (like as in the effect of concentration) as it
is serving a controlling mechanism at the last level. However the kinetics of the release
is increased by increasing the flow rate. In particular, by changing the state of the flow to
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the continuous state gradient of the concentration between the sample and the medium
is increased.
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Figure 10. Comparison of the al s f ili i l f -20
DE at three different flow rates of 0, 7.5 and 23.5 mL/s.
Figure 9 shows the variation of the kinetic of the burst release, diffusion coefficient and
osmotic pressure along with increasing the flow rate. As shown in Figure 9 the constants
related to the burst release, diffusion and osmotic pressure are all increased by increasing
the flow rate. This increase is more noticeable respectively for the kinetic of burst, osmotic
pressure and diffusion coefficient.
3.3. Specific-Model Development and Validation
For analyzing the phenomenon of release, Equation (16) considering three mechanisms
of burst, diffusion and osmosis was fitted to the experimental results of the diclofenac
release from PU samples at different drug percentages and flow rates. It is shown that the
fitting curves with the experimental results in Figure 4 are satisfactory. The parameters
resulted from the fittings are summarized in Table 1. The correlation between these values
makes it possible to predict the release for the other percentages of drug loaded or other
flow rates.
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For finding the correlation of the kinetic constants of the occurring mechanisms, (kb,
De and ∆π) with the concentration and flow rate, related equation between rate constants
with Arrhenius and linear equations were used respectively.
For calculating the rate constants with varying drug concentration, an Arrhenius type
equation was used. The applied equation is presented as Equation (23).






where k is the constant of the mechanisms, A is the constant of the Arrhenius form equation
and C is the initial concentration value.
The kinetic constants of the mechanisms in accordance to the concentration are traced
in the form of the Arrhenius, and the results show good correlation (shown in Figure 11).
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Figure 11. Correlation between (a) diffusion coefficient, (b) burst constant, (c) osmotic pressure in accordance to the
concentration adapted to the Arrhenius equation.
For calculating the rate constants with varying flow rate, the linear equation was taken
into account. Applied equation is presented as Equation (24).
Q = A·k (24)
where k is the constant of the mechanisms, A is the constant of the equation and Q is the
flow rate value.
The kinetic constants of the mechanisms in accordance to the concentration are traced
in the form of the linear, the results shows good correlation (shown in Figure 12). This
correlation were used to calculate the values related to the other flow rates.
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Figure 13a,b show the predicted drug release profile by the model for the PU matrix
loaded with 15% diclofenac at the flow rate of 7.5 mL/s, and 20% diclofenac at the flow
rate of 6.5 mL/s compared to the experimental release data. It can be noted that in both
cases a good correlation exists between the model and experimental results.








Figure 13. Comparison of the predicted release profile obtained by the model and the experi-
mental data for the case (a) PU-15%DE-Q7.5 mL/s, (b) PU-20%DE-Q6.5 mL/s. 
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mechanisms that have their own equations can be used (there is a problem using mecha-
nisms such as ion-exchange). This method is considered for the in vitro case, and the in 
vivo interactions between the drug and tissue components, such as binding-unbinding 
are not yet taken into consideration. 
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4. Perspective
This method can be applied for any kind of drug-d livery agent by consider ng
differ nt effective parameters on the r lease (such as, temperature, pH, flow rate, initial
d ug percen age, etc.) in rder to op imize the factors i design of these gen s adapt d
to the environment used. However, there are some limitations in this method, such as
only the ec nisms t at have their ow equations can be used (there is a proble using
mechanisms such as ion-exchange). This method is considered for the in vitro c se, and the
in vivo interactions between the drug and tissue components, such as binding-unbinding
are not yet taken into consideration.
5. Conclusions
A mathematical method to predict the release profile based on physical mechanisms
contributing to the release has been developed. In the case studied, three mechanisms
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for the delivery agent were identified: burst release, diffusion and osmosis. Experimental
in vitro data were of the drug release from PU samples with three different concentrations
at three different flow rates. The influence of flow rate and concentration on drug release
ratios has been highlighted. The results showed that by increasing the drug percentage
and flow rate, the contributions of the burst release and osmotics are increased. The effect
of the initial concentration was more significant on the burst release and flow rate affected
the osmosis mechanism more. It is worth noting that the period of the contribution of a
mechanism is also important. Where even though, high proportion of the drug was released
by the diffusion mechanism, its contribution decreased with increasing the two parameters.
The former can be explained by the fact that diffusion was controlling mechanism almost
at the late periods of the release. It is remarkable that the kinetics of the release by three
mechanisms of burst, osmotic and diffusion when increasing the two parameters are
also increased.
The correlation between the values obtained by the model was helpful in predicting
the release behavior at the other range values of that parameter. These parameters have
also affected the physical properties, such as free volume fraction and permeability of the
materials, which have an influence on the release kinetic. It is shown that the flow rate has
linearly affected the osmotic pressure and hydraulic permeability of the samples.
Different parameters can influence the mechanisms contributing to the release. There-
fore, the mechanistic models can consider these effects reasonably in order to predict the
release behavior and optimize the design of the delivery agent adapted to the environment
in use.
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